Skip to main content

MEDIFAST INC

For the period ended Mar 31, 2026. Filed May 4, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 4, 2026

MED$13.37+4.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. – Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(U.S. dollars in thousands, except per share amounts)

Three months ended March 31,
20262025
Revenue$76,044$115,728
Cost of sales24,28831,483
Gross profit51,75684,245
Selling, general, and administrative55,05185,507
Loss from operations(3,295)(1,262)
Other income
Interest income1,3791,301
Other income (expense)(25)487
1,3541,788
Income (loss) before provision for income taxes(1,941)526
Provision for income taxes1811,298
Net loss$(2,122)$(772)
Loss per share - basic$(0.19)$(0.07)
Loss per share - diluted$(0.19)$(0.07)
Weighted average shares outstanding
Basic11,00610,948
Diluted11,00610,948

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

Three months ended March 31,
20262025
Net loss$(2,122)$(772)
Other comprehensive income (loss), net of tax:
Unrealized gains (losses) on investment securities(201)59
Comprehensive loss$(2,323)$(713)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.